AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Gastro-Intestinal Cancer

GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care NCT05391126NA1 site๐Ÿ“ Lexington Reema A. Patel ยท Tests: Irinotecan The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy. NCT06019455n/a1 site๐Ÿ“ Guangzhou Sun Yat-sen University Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC NCT06553885Phase 21 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Enfortumab Vedotin Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1 NCT06917963NA2 sites๐Ÿ“ Gdansk๐Ÿ“ Gdynia Medical University of Gdansk ยท Tests: Intensified intravenous omeprazole therapy (loading dose 80 mg IV, then 40 mg IV twice daily at 6:00 AM and 6:00 PM), Sโ€ฆ Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05) NCT07165847Phase 21 site๐Ÿ“ Chongqing Daping Hospital and the Research Institute of Surgery of thโ€ฆ ยท Tests: Iparomlimab and Tuvonralimab, Oxaliplatin, Tegafur, Radiotherapy The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site๐Ÿ“ Columbus Ohio State University Comprehensive Cancer Center ยท Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC NCT07284992Phase 21 site๐Ÿ“ Jinan Shandong Provincial Hospital ยท Tests: short-term radiotherapy combined with Adebrelimab and capox, long-term radiotherapy combined with Adebrelimab and capox VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites๐Ÿ“ Santa Rosa๐Ÿ“ Hartford๐Ÿ“ Washington D.C. VM Oncology, LLC ยท Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06) NCT06780111Phase 1, Phase 252 sites๐Ÿ“ Pittsburgh๐Ÿ“ Natal๐Ÿ“ Porto Alegre Merck Sharp & Dohme LLC ยท Tests: Pembrolizumab, I-DXd, Leucovorin, Levoleucovorin, 5-Fluorouracil (5-FU) Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer NCT07367516Phase 1, Phase 230 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Fuzhou Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ยท Tests: TQB6411 Injection A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer NCT07692204Phase 21 site๐Ÿ“ Shanghai Sanofi ยท Tests: SAR445877 Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors NCT06821048Phase 11 site๐Ÿ“ Hangzhou Weijia Fang, MD ยท Tests: Intraperitoneal infusion of FAST CEA-targeted CAR-T Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer NCT06121700Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: Radiotherapy targeted to the primary lesion, Radiotherapy targeted to the metastatic lesions, Anti-PD-1 monoclonal antiโ€ฆ An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Zhengzhou๐Ÿ“ Hangzhou Beijing Tide Pharmaceutical Co., Ltd ยท Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection NIMA-Colon Cancer Study NCT07534852NA1 site๐Ÿ“ Mรกlaga Fundaciรณn Pรบblica Andaluza para la Investigaciรณn de Mรกlaga โ€ฆ ยท Tests: Standard hypercaloric-hyperproteic nutritional supplementation, HMB-enriched hypercaloric-hyperproteic nutritional suppโ€ฆ A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease NCT06607458Phase 220 sites๐Ÿ“ Duarte๐Ÿ“ Santa Monica๐Ÿ“ Miami Delcath Systems Inc. ยท Tests: Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab, Trifluridine-tipiracil โ€ฆ Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer NCT06509126Phase 31 site๐Ÿ“ Naples National Cancer Institute, Naples ยท Tests: Panitumumab, Irinotecan, 5-fluorouracil, L-folinic acid Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis NCT07029152NA8 sites๐Ÿ“ Bruges๐Ÿ“ Brussels๐Ÿ“ Brussels Universitair Ziekenhuis Brussel ยท Tests: Anal smear, Self-administered questionnaire, EQ-5D-5L questionnaire, High Resolution Anoscopy (HRA) A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma NCT06843889Phase 21 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: Toripalimab (240mg day1, Q3W*3cycle) Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors NCT07487168Phase 11 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Mitomycin C (MMC), Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) A Study of Tucatinib and Trastuzumab in People With Rectal Cancer NCT05672524Phase 27 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Trastuzumab, Tucatinib Advanced Therapies for Liver Metastases NCT04622423n/a1 site๐Ÿ“ Milan IRCCS San Raffaele A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites๐Ÿ“ Beverly Hills๐Ÿ“ San Francisco๐Ÿ“ Westwood, Los Angeles Fore Biotherapeutics ยท Tests: Plixorafenib 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique NCT06300879NA1 site๐Ÿ“ Shanghai Huashan Hospital ยท Tests: Performing totally laparoscopic proximal gastrectomy with esophagogastrostomy by fissure technique Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma NCT06476067n/a2 sites๐Ÿ“ Nagoya๐Ÿ“ Chลซล City of Hope Medical Center ยท Tests: Surgery Sacituzumab Govitecan in Metastatic Colorectal Cancer NCT06243393Phase 2, Phase 31 site๐Ÿ“ Heidelberg University Hospital Heidelberg ยท Tests: Sacituzumab Govitecan (SG), Physicians Choice (PhC). Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer NCT07352280n/a1 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer NCT07313579n/a1 site๐Ÿ“ Kyiv Ukrainian Society of Clinical Oncology ยท Tests: curative-intent surgery + HIPEC
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy